Dr. Subramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8081 Innovation Park Dr
Level 4 - White Oak Clinic
Fairfax, VA 22031Phone+1 571-472-1380Fax+1 571-472-1294
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2007 - 2010
St Luke's HospitalResidency, Internal Medicine, 2003 - 2006
Sri Ramachandra Medical CollegeClass of 2000
Certifications & Licensure
MO State Medical License 2006 - 2026
VA State Medical License 2021 - 2026
KS State Medical License 2015 - 2025
TN State Medical License 2012 - 2018
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Start of enrollment: 2011 Apr 01
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- EGFR testing practices, treatment choice and clinical outcomes in advanced NSCLC in a real-world setting: A retrospective analysis of a US-based electronic health reco...Janakiraman Subramanian, Jeffrey Gregg, Mehmet Berktas, Jingyi Li, Natasha B Leighl
Lung Cancer. 2025-03-01 - Long-Term Survival by Number of Immune Checkpoint Inhibitors in PD-L1-Negative Metastatic NSCLC: A Systematic Review and Meta-Analysis.Ben Ponvilawan, Dhruv Bansal, Nagla Abdel Karim, Rahul Ramakrishnan, Janakiraman Subramanian
JAMA Network Open. 2025-02-03 - State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs.Nagla Abdel Karim, Ahmed Magdy Rabea, Philip C Mack, Janakiraman Subramanian, Ehab Khalil
JTO Clinical and Research Reports. 2025-01-01
Press Mentions
The Role of Chemotherapy in the Treatment of Stage II Nasopharyngeal Carcinoma: Retrospective Analysis of the National Cancer DatabaseFebruary 21st, 2020
Genomic Testing Solves Cancer MisdiagnosisMarch 14th, 2019
Lantern Pharma Announces Positive Clinical Update from Ongoing Phase 2 HARMONIC™ Clinical Trial for Never Smokers with Advanced NSCLC, Including an 86% Clinical Benefit Rate in the Initial Patient CohortAugust 8th, 2024
Professional Memberships
- Member
Other Languages
- Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
